Elypta AB
Description: Elypta develops liquid biopsy tech for early cancer detection by analyzing GAGome biomarkers & using AI to spot cancer signatures noninvasively.
Country: Sweden
Based in: Stockholm
Founded: 2017
Funding Stage: Series A/B
Tags: ['diagnostics', 'cancer', 'liquid biopsy', 'early detection']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
